NHLBI TOPMed - NHGRI CCDG: Pakistan Risk of Myocardial Infarction Study (PROMIS)
Biomarkers (5)
- creatinine - Creatinine measures at time of recruitment (phv00556068.v1.p1)
- hdl_mgdl - HDL measured at time of recruitment (phv00556067.v1.p1)
- random_glucose_mgdl - Random blood glucose (mg/dl) at time of recruitment (phv00556069.v1.p1)
- total_cholesterol_mgdl - Total Cholesterol measures at time of recruitment (phv00556066.v1.p1)
- triglycerides_mgdl - Triglycerides measured at time of recruitment (phv00556065.v1.p1)
Demographics (2)
- age - Age at recruitment and consent (phv00556064.v1.p1)
- SEX - Reported sex (phv00556060.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00556072.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00556071.v1.p1)
- CCDG_SAMPLE_ID - Sample ID in the CCDG project (phv00556079.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00556059.v1.p1)
- Funding_Source - Project funding source (phv00556075.v1.p1)
- IS_TUMOR - Tumor status (phv00556073.v1.p1)
- SAMPLE_ID - Sample ID (phv00556070.v1.p1)
- SAMPLE_ID - Sample ID (phv00556062.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00556074.v1.p1)
- Study_Name - TOPMed-assigned short study name (phv00556078.v1.p1)
- SUBJECT_ID - Subject_id (phv00556063.v1.p1)
- SUBJECT_ID - Subject ID (phv00556058.v1.p1)
- SUBJECT_ID - Subject ID (phv00556061.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00556076.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00556077.v1.p1)